Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis
CONCLUSIONS: We found a strong association between treatment effects for EFS and OS, indicating that improvements in EFS are likely to be predictive of improvements in OS. EFS may therefore be a reliable surrogate for OS after neoadjuvant therapy in r-NSCLC.PMID:37850939 | DOI:10.1080/14737140.2023.2272645
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Authors: Gyula Ostoros Robert Hettle Nefeli Georgoulia Mehmet Berktas Pratibha Chander Ignacio Diaz Perez Anne-Marie Couto Christian Eichinger Polly Field Peter Morten Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Lung Cancer | Neoadjuvant Therapy | Non-Small Cell Lung Cancer | Statistics